Bulk Manufacturer of Controlled Substances Application: Patheon Pharmaceuticals, Inc., 15571 [2016-06539]

Download as PDF Federal Register / Vol. 81, No. 56 / Wednesday, March 23, 2016 / Notices Dated: March 14, 2016. Louis J. Milione, Deputy Assistant Administrator. DEPARTMENT OF LABOR [FR Doc. 2016–06548 Filed 3–22–16; 8:45 am] Occupational Safety and Health Administration BILLING CODE 4410–09–P [Docket No. OSHA–2016–0008] DEPARTMENT OF JUSTICE Whistleblower Protection Advisory Committee (WPAC) Drug Enforcement Administration AGENCY: Occupational Safety and Health Administration (OSHA), Labor. ACTION: Announcement of a meeting of WPAC. [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Application: Patheon Pharmaceuticals, Inc. ACTION: Notice of application. Registered bulk manufacturers of the affected basic class, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before May 23, 2016. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated her authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (‘‘Deputy Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on December 10, 2015, Patheon Pharmaceuticals, Inc., 2110 E. Galbraith Road, Cincinnati, Ohio 45237 applied to be registered as a bulk manufacturer of gamma hydroxybutyric acid (2010) a basic class of controlled substance listed in schedule I. The company plans to manufacture the listed controlled substance for product development. jstallworth on DSK7TPTVN1PROD with NOTICES DATES: Dated: March 14, 2016. Louis J. Milione, Deputy Assistant Administrator. [FR Doc. 2016–06539 Filed 3–22–16; 8:45 am] BILLING CODE 4410–09–P VerDate Sep<11>2014 15:26 Mar 22, 2016 Jkt 238001 WPAC will meet April 26, 2016, in Washington, DC. DATES: WPAC meeting: WPAC will meet from 9:00 a.m. to 4:00 p.m., E.T., Tuesday, April 26, 2015. Written comments, requests to speak, speaker presentations, and requests for special accommodation: You must submit (postmark, send, transmit) comments, requests to address the WPAC meeting, speaker presentations (written or electronic), and requests for special accommodations for the WPAC meeting by April 12, 2016. ADDRESSES: WPAC meeting: WPAC will meet in Room N–4437 A–C, U.S. Department of Labor, Francis Perkins Building, 200 Constitution Avenue NW., Washington, DC 20210. Submission of comments, requests to speak, and speaker presentations: You may submit comments, requests to speak at the WPAC meeting, and speaker presentations using one of the following methods: Electronically: You may submit materials, including attachments, electronically at http:// www.regulations.gov, which is the Federal eRulemaking Portal. Follow the on-line instructions for submissions. Facsimile (Fax): If your submission, including attachments, does not exceed 10 pages, you may fax it to the OSHA Docket Office at (202) 693–1648. Regular mail, express mail, hand delivery, or messenger (courier) service: You may submit your materials to the OSHA Docket Office, Docket No. OSHA–2016–0008, Room N–2625, U.S. Department of Labor, 200 Constitution Avenue NW., Washington, DC 20210; telephone (202) 693–2350 (TTY (877) 889–5627). OSHA’s Docket Office accepts deliveries (hand deliveries, express mail, and messenger service) during normal business hours, 8:15 a.m.–4:45 p.m., E.T., weekdays. Requests for special accommodations: Please submit any requests for special accommodations to attend the WPAC meeting to Ms. Gretta Jameson, OSHA, Office of Communications, Room N– 3647, U.S. Department of Labor, 200 SUMMARY: PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 15571 Constitution Avenue NW., Washington, DC 20210; telephone (202) 693–1999; email jameson.grettah@dol.gov. Instructions: Your submissions must include the agency name and docket number for this Federal Register notice (Docket No. OSHA–2016–0008). Due to security-related procedures, submissions by regular mail may experience significant delays. Please contact the OSHA Docket Office for information about security procedures for making submissions. For additional information on submitting comments, requests to speak, and speaker presentations, see the SUPPLEMENTARY INFORMATION section of this notice. FOR FURTHER INFORMATION CONTACT: For press inquiries: Mr. Frank Meilinger, Director, OSHA Office of Communications, Room N–3647, U.S. Department of Labor, 200 Constitution Avenue NW., Washington, DC 20210; telephone (202) 693–1999; email meilinger.francis2@dol.gov. For general information about WPAC and WPAC meetings: Mr. Anthony Rosa, OSHA, Directorate of Whistleblower Protection Programs, Room N–4618, U.S. Department of Labor, 200 Constitution Avenue NW., Washington, DC 20210; telephone (202) 693–2199; email osha.dwpp@dol.gov. SUPPLEMENTARY INFORMATION: WPAC Meeting WPAC will meet Tuesday, April 26, 2015, in Washington, DC. WPAC meetings are open to the public. The tentative agenda of the WPAC meeting includes: Remarks from the Assistant Secretary of Labor for Occupational Safety and Health (OSHA); Remarks from the Director of the Directorate of Whistleblower Protection Programs; Presentations from other federal agencies with whistleblower programs; Railroad worker whistleblower presentation; Public comments; Work Group presentations; and, Old business. OSHA transcribes WPAC meetings and prepares detailed minutes of the meetings. OSHA places the meeting transcripts and minutes in the public record of the WPAC meeting. The public record also includes Work Group reports, speaker presentations, comments and other materials submitted to WPAC. WPAC Work Groups The WPAC work groups (Outreach and Training) will meet on April 25, 2016. These work group meetings will be open to the public. The purpose of the work groups is to provide recommendations to the full WPAC E:\FR\FM\23MRN1.SGM 23MRN1

Agencies

[Federal Register Volume 81, Number 56 (Wednesday, March 23, 2016)]
[Notices]
[Page 15571]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-06539]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Patheon 
Pharmaceuticals, Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic class, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration in accordance with 21 CFR 
1301.33(a) on or before May 23, 2016.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/ODW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated her 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Deputy Assistant Administrator of the DEA Office of Diversion 
Control (``Deputy Assistant Administrator'') pursuant to section 7 of 
28 CFR part 0, appendix to subpart R.
    In accordance with 21 CFR 1301.33(a), this is notice that on 
December 10, 2015, Patheon Pharmaceuticals, Inc., 2110 E. Galbraith 
Road, Cincinnati, Ohio 45237 applied to be registered as a bulk 
manufacturer of gamma hydroxybutyric acid (2010) a basic class of 
controlled substance listed in schedule I.
    The company plans to manufacture the listed controlled substance 
for product development.

    Dated: March 14, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-06539 Filed 3-22-16; 8:45 am]
 BILLING CODE 4410-09-P